Cinieri, S., Chan, A., Altundag, K., Vandebroek, A., Tubiana-Mathieu, N., Barnadas, A., . . . Coskun, U. (2017). Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
Chicago Style (17th ed.) CitationCinieri, S., et al. Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer. 2017.
MLA (9th ed.) CitationCinieri, S., et al. Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer. 2017.
Warning: These citations may not always be 100% accurate.